A Cardesa Selected Research

alpha- (1,4- dioxido- 3- methylquinoxalin- 2- yl)- N- methylnitrone

2/2001

Expression of cyclin D1 and p53 and its correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2,6-dimethylnitrosomorpholine administration in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Cardesa Research Topics

Disease

6	Neoplasms (Cancer) 01/2004 - 03/2000
4	Carcinoma (Carcinomatosis) 07/2018 - 01/2001
2	Lymphoma (Lymphomas) 06/2000 - 03/2000
1	Carcinoid Tumor (Carcinoid) 07/2018
1	Mucoepidermoid Carcinoma 08/2010
1	Adenocarcinoma 02/2009
1	Neoplasm Metastasis (Metastasis) 02/2009
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2006
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2006
1	Aneuploidy (Aneuploid) 06/2004
1	Breast Neoplasms (Breast Cancer) 01/2004
1	Mucormycosis 06/2002
1	Sinusitis 06/2002
1	IGA Glomerulonephritis (IGA Nephropathy) 07/2001
1	Renal Insufficiency (Renal Failure) 07/2001
1	Atrophy 07/2001
1	Fibrosis (Cirrhosis) 07/2001
1	Glomerulonephritis 07/2001
1	Sclerosis 07/2001
1	Proteinuria 07/2001
1	Colorectal Neoplasms (Colorectal Cancer) 04/2001
1	Carcinogenesis 02/2001
1	Peptic Esophagitis (Reflux Esophagitis) 02/2001
1	Metaplasia 01/2001
1	Hyperplasia 07/2000
1	Carcinoma in Situ 07/2000
1	Angiomyolipoma 04/2000
1	Persistent Infection 01/2000
1	Infections 01/2000

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 01/2006 - 04/2001
3	Proteins (Proteins, Gene)FDA Link 04/2001 - 03/2000
2	Biological ProductsIBA 07/2018 - 08/2010
2	Messenger RNA (mRNA)IBA 04/2001 - 03/2000
1	Keratin-20 (Cytokeratin 20)IBA 02/2009
1	Keratin-7 (Cytokeratin 7)IBA 02/2009
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2004
1	trioctyl phosphine oxide (TOPO)IBA 01/2004
1	AnthracyclinesIBA 01/2004
1	Amphotericin B (Amphotericin)FDA LinkGeneric 06/2002
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2001
1	CreatinineIBA 07/2001
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2001
1	RNA (Ribonucleic Acid)IBA 04/2001
1	Protein Isoforms (Isoforms)IBA 04/2001
1	alpha- (1,4- dioxido- 3- methylquinoxalin- 2- yl)- N- methylnitroneIBA 02/2001
1	CarcinogensIBA 02/2001
1	Cyclin D1IBA 02/2001
1	CathepsinsIBA 01/2001
1	Peptide Hydrolases (Proteases)FDA Link 01/2001
1	Cysteine Proteases (Cysteine Protease)IBA 01/2001
1	Keratins (Keratin)IBA 07/2000
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 06/2000
1	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2000
1	SugarsIBA 04/2000
1	hemozoinIBA 01/2000
1	FibrinIBA 01/2000

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 07/2018 - 01/2004
1	Neoadjuvant Therapy 01/2004
1	Jejunostomy 02/2001